Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized Trial of COBRA PzF Stenting to Reduce the Duration of Triple Therapy: The COBRA-REDUCE Trial.
Byrne RA, Colleran R, Coughlan JJ, Jauhar R, Maillard L, De Labriolle A, Maeng M, Croft C, Brunner M, Leistner D, Zrenner B, Kollum M, Laugwitz KL, Xhepa E, Mayer K, Lahu S, Joner M, Kirtane A, Mehran R, Barakat M, Urban P, Cutlip DE, Kastrati A; COBRA-REDUCE Investigators. Byrne RA, et al. Among authors: lahu s. Circ Cardiovasc Interv. 2024 Oct;17(10):e013735. doi: 10.1161/CIRCINTERVENTIONS.123.013735. Epub 2024 Oct 15. Circ Cardiovasc Interv. 2024. PMID: 39405373 Clinical Trial.
Amugulang virus, a novel hantavirus harboured by small rodents in Hulunbuir, China.
Han X, Zhang L, Zhang M, Xin Q, Zhao Y, Wen Y, Deng H, Zhu J, Dai Q, Han M, Yang T, Lahu S, Jiang F, Chen Z. Han X, et al. Among authors: lahu s. Emerg Microbes Infect. 2024 Dec;13(1):2396893. doi: 10.1080/22221751.2024.2396893. Epub 2024 Sep 5. Emerg Microbes Infect. 2024. PMID: 39178299 Free PMC article.
Incidence and pattern of urgent revascularization in acute coronary syndromes treated with ticagrelor or prasugrel.
Aytekin A, Scalamogna M, Coughlan JJ, Lahu S, Ndrepepa G, Menichelli M, Mayer K, Wöhrle J, Bernlochner I, Witzenbichler B, Hochholzer W, Sibbing D, Angiolillo DJ, Hemetsberger R, Tölg R, Valina C, Müller A, Kufner S, Liebetrau C, Xhepa E, Hapfelmeier A, Sager HB, Joner M, Richardt G, Laugwitz KL, Neumann FJ, Schunkert H, Schüpke S, Kastrati A, Cassese S. Aytekin A, et al. Among authors: lahu s. Clin Res Cardiol. 2024 Jul;113(7):1060-1069. doi: 10.1007/s00392-024-02454-x. Epub 2024 May 13. Clin Res Cardiol. 2024. PMID: 38740722 Free PMC article. Clinical Trial.
Modified balloons to prepare severely calcified coronary lesions before stent implantation: a systematic review and meta-analysis of randomized trials.
Scalamogna M, Kuna C, Voll F, Aytekin A, Lahu S, Kessler T, Kufner S, Rheude T, Sager HB, Xhepa E, Wiebe J, Joner M, Ndrepepa G, Kastrati A, Cassese S. Scalamogna M, et al. Among authors: lahu s. Clin Res Cardiol. 2024 Jul;113(7):995-1005. doi: 10.1007/s00392-023-02324-y. Epub 2023 Nov 6. Clin Res Cardiol. 2024. PMID: 37930402 Free PMC article. Review.
Plasma Soluble Glycoprotein VI, Platelet Function, Bleeding, and Ischemic Events in Patients Undergoing Elective Percutaneous Coronary Intervention.
Lahu S, Adler K, Mayer K, Hein-Rothweiler R, Bernlochner I, Ndrepepa G, Schüpke S, Holdenrieder S, Bongiovanni D, Laugwitz KL, Schunkert H, Gawaz M, Massberg S, Kastrati A, Münch G. Lahu S, et al. Thromb Haemost. 2024 Apr;124(4):297-306. doi: 10.1055/s-0043-1772221. Epub 2023 Aug 17. Thromb Haemost. 2024. PMID: 37591289
Derivation and validation of the ISAR score to predict the risk of repeat percutaneous coronary intervention for recurrent drug-eluting stent restenosis.
Coughlan JJ, Aytekin A, Lahu S, Scalamogna M, Wiebe J, Pinieck S, Kufner S, Xhepa E, Joner M, Kuna C, Voll F, Laugwitz KL, Schunkert H, Kastrati A, Cassese S. Coughlan JJ, et al. Among authors: lahu s. EuroIntervention. 2023 Apr 3;18(16):e1328-e1338. doi: 10.4244/EIJ-D-22-00860. EuroIntervention. 2023. PMID: 36785947 Free PMC article. Clinical Trial.
Prior Myocardial Infarction and Treatment Effect of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndromes - A Post-hoc Analysis of the ISAR-REACT 5 Trial.
Lahu S, Scalamogna M, Ndrepepa G, Menichelli M, Valina C, Hemetsberger R, Witzenbichler B, Bernlochner I, Joner M, Xhepa E, Hapfelmeier A, Kufner S, Sager HB, Mayer K, Kessler T, Laugwitz KL, Richardt G, Schunkert H, Neumann FJ, Kastrati A, Cassese S. Lahu S, et al. J Am Heart Assoc. 2022 Dec 20;11(24):e027257. doi: 10.1161/JAHA.122.027257. Epub 2022 Dec 14. J Am Heart Assoc. 2022. PMID: 36515247 Free PMC article. Clinical Trial.
Association between Platelet Count and Treatment Effect of Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes.
Koch T, Lahu S, Coughlan JJ, Cassese S, Voll F, Ndrepepa G, Menichelli M, Valina C, Hemetsberger R, Witzenbichler B, Bernlochner I, Joner M, Xhepa E, Mayer K, Kessler T, Laugwitz KL, Richardt G, Schunkert H, Angiolillo DJ, Sibbing D, Kastrati A, Kufner S. Koch T, et al. Among authors: lahu s. Thromb Haemost. 2023 Apr;123(4):464-477. doi: 10.1055/a-1988-5047. Epub 2022 Nov 28. Thromb Haemost. 2023. PMID: 36442805 Free PMC article. Clinical Trial.
The effect of a Prasugrel- vs. a Ticagrelor-based strategy on total ischaemic and bleeding events in patients with acute coronary syndromes.
Aytekin A, Coughlan JJ, Ndrepepa G, Cassese S, Lahu S, Kufner S, Mayer K, Xhepa E, Gewalt S, Joner M, Hapfelmeier A, Angiolillo DJ, Menichelli M, Richardt G, Neumann FJ, Schunkert H, Kastrati A. Aytekin A, et al. Among authors: lahu s. Eur Heart J Cardiovasc Pharmacother. 2023 Apr 10;9(3):231-239. doi: 10.1093/ehjcvp/pvac067. Eur Heart J Cardiovasc Pharmacother. 2023. PMID: 36434779 Clinical Trial.
28 results